Physician

Syed Egbal Ahmed, M.D.

According to 2025 Medicare claims, Syed Ahmed, M.D. (NPI: 1700880697) practices medical oncology in the Sebring, FL market, with the plurality of this provider's patient population coming from Highlands, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 33870-1204.

Ahmed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,217 traditional Medicare patients, billed 319,414 HCPCS/CPT codes, and received $4,505,052 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,694 prescription claims across 355 beneficiaries totaling $5,508,452 in drug costs, led by Revlimid (Lenalidomide). DME data shows 222 claims. Open Payments data shows 295 records totaling $6,885. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,565,725 to $5,508,452. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $10,247 to $16,953.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,247	391,938	$3,946,982
2016	1,386	404,187	$4,322,331
2017	1,498	290,433	$3,973,507
2018	1,433	255,467	$3,928,650
2019	1,500	294,683	$4,011,184
2020	1,396	342,166	$4,070,213
2021	1,477	336,892	$4,719,074
2022	1,256	333,143	$4,744,898
2023	1,252	321,462	$4,364,821
2024	1,217	319,414	$4,505,052

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	241	1,047	$1,565,725
2016	249	1,092	$2,012,961
2017	258	1,049	$2,072,403
2018	250	1,121	$2,734,827
2019	247	1,073	$2,905,485
2020	292	1,244	$2,509,107
2021	309	1,287	$2,915,430
2022	311	1,403	$4,016,934
2023	352	1,485	$3,912,769
2024	355	1,694	$5,508,452

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	38	215	$20,371
2016	35	155	$7,674
2017	N/R	37	$3,939
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	40	$3,439
2021	N/R	45	$2,611
2022	N/R	51	$1,949
2023	N/R	212	$17,868
2024	N/R	222	$12,469

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	627	1,560	$94
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	269	350	$13
96372	Injection of drug or substance under skin or into muscle	326	1,450	$10
36415	Insertion of needle into vein for collection of blood sample	801	2,343	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	780	2,379	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	53	1,407	$883,895
Calquence	Acalabrutinib Maleate	31	930	$469,528
Imbruvica	Ibrutinib	24	672	$395,133
Brukinsa	Zanubrutinib	26	780	$389,921
Stivarga	Regorafenib	12	336	$269,066

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	82	$9,492
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	22	$945
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	47	$883
J8521	Capecitabine, oral, 500 mg	N	N/R	11	$416
E0562	Humidifier, heated, used with positive airway pressure device	Y	N/R	18	$278

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	295	$6,885	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Syed Egbal Ahmed, M.D.?

Tedicare shows public-source Medicare data for Syed Egbal Ahmed, M.D. (NPI 1700880697), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Syed Egbal Ahmed, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Syed Egbal Ahmed, M.D.?

Syed Egbal Ahmed, M.D. is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Syed Egbal Ahmed, M.D. have Open Payments data?

Syed Egbal Ahmed, M.D. has 295 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.